본문 바로가기
HOME> 논문 > 논문 검색상세

논문 상세정보

The journal of immunology : official journal of the American Association of Immunologists v.198 no.3, 2017년, pp.1308 - 1319   SCI SCIE
본 등재정보는 저널의 등재정보를 참고하여 보여주는 베타서비스로 정확한 논문의 등재여부는 등재기관에 확인하시기 바랍니다.

Selective IRAK4 Inhibition Attenuates Disease in Murine Lupus Models and Demonstrates Steroid Sparing Activity

Dudhgaonkar, Shailesh (Biocon Bristol-Myers Squibb Research Center, Bangalore 560099, India ) ; Ranade, Sourabh (Biocon Bristol-Myers Squibb Research Center, Bangalore 560099, India ) ; Nagar, Jignesh (Biocon Bristol-Myers Squibb Research Center, Bangalore 560099, India ) ; Subramani, Siva (Biocon Bristol-Myers Squibb Research Center, Bangalore 560099, India ) ; Prasad, Durga Shiv (Biocon Bristol-Myers Squibb Research Center, Bangalore 560099, India ) ; Karunanithi, Preethi (Biocon Bristol-Myers Squibb Research Center, Bangalore 560099, India ) ; Srivastava, Ratika (Biocon Bristol-Myers Squibb Research Center, Bangalore 560099, India ) ; Venkatesh, Kamala (Biocon Bristol-Myers Squibb Research Center, Bangalore 560099, India ) ; Selvam, Sabariya (Biocon Bristol-Myers Squibb Research Center, Bangalore 560099, India ) ; Krishnamurthy, Prasad (Biocon Bristol-Myers Squibb Research Center, Bangalore 560099, India ) ; Mariappan, T. Thanga (Biocon Bristol-Myers Squibb Research Center, Bangalore 560099, India ) ; Saxena, Ajay (Biocon Bristol-Myers Squibb Research Center, Bangalore 560099, India ) ; Fan, Li (Immunology Discovery, Bristol-Myers Squibb, Princeton, NJ 08543 ) ; Stetsko, Dawn K. (Immunology Discovery, Bristol-Myers Squibb, Princeton, NJ 08543 ) ; Holloway, Deborah A. (Im ) ; Li, Xin ; Zhu, Jun ; Yang, Wen-Pin ; Ruepp, Stefan ; Nair, Satheesh ; Santella, Joseph ; Duncia, John ; Hynes, John ; McIntyre, Kim W. ; Carman, Julie A. ;
  • 초록  

    The serine/threonine kinase IL-1R–associated kinase (IRAK)4 is a critical regulator of innate immunity. We have identified BMS-986126, a potent, highly selective inhibitor of IRAK4 kinase activity that demonstrates equipotent activity against multiple MyD88-dependent responses both in vitro and in vivo. BMS-986126 failed to inhibit assays downstream of MyD88-independent receptors, including the TNF receptor and TLR3. Very little activity was seen downstream of TLR4, which can also activate an MyD88-independent pathway. In mice, the compound inhibited cytokine production induced by injection of several different TLR agonists, including those for TLR2, TLR7, and TLR9. The compound also significantly suppressed skin inflammation induced by topical administration of the TLR7 agonist imiquimod. BMS-986126 demonstrated robust activity in the MRL/ lpr and NZB/NZW models of lupus, inhibiting multiple pathogenic responses. In the MRL/ lpr model, robust activity was observed with the combination of suboptimal doses of BMS-986126 and prednisolone, suggesting the potential for steroid sparing activity. BMS-986126 also demonstrated synergy with prednisolone in assays of TLR7- and TLR9-induced IFN target gene expression using human PBMCs. Lastly, BMS-986126 inhibited TLR7- and TLR9-dependent responses using cells derived from lupus patients, suggesting that inhibition of IRAK4 has the potential for therapeutic benefit in treating lupus.


 활용도 분석

  • 상세보기

    amChart 영역
  • 원문보기

    amChart 영역

원문보기

무료다운로드
  • 원문이 없습니다.
유료다운로드

유료 다운로드의 경우 해당 사이트의 정책에 따라 신규 회원가입, 로그인, 유료 구매 등이 필요할 수 있습니다. 해당 사이트에서 발생하는 귀하의 모든 정보활동은 NDSL의 서비스 정책과 무관합니다.

원문복사신청을 하시면, 일부 해외 인쇄학술지의 경우 외국학술지지원센터(FRIC)에서
무료 원문복사 서비스를 제공합니다.

NDSL에서는 해당 원문을 복사서비스하고 있습니다. 위의 원문복사신청 또는 장바구니 담기를 통하여 원문복사서비스 이용이 가능합니다.

이 논문과 함께 출판된 논문 + 더보기